The pepsin hydrolysate of bovine lactoferrin causes a collapse of the membrane potential in Escherichia coli O157:H7

Probiotics and Antimicrobial Proteins

Volumn 2, Issue 2, 2010, Pages 112-119

  Murdock, Christopher ^a   Chikindas, Michael L ^a   Matthews, Karl R ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Antimicrobial peptides; E. coli O157:H7; Lactoferrin; Mode of action

Indexed keywords

ADENOSINE TRIPHOSPHATE; LACTOFERRIN; PEPSIN A; POTASSIUM ION; PROTEIN HYDROLYSATE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; CELL DEATH; CELL LEVEL; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; ESCHERICHIA COLI O157; EXTRACELLULAR SPACE; MEMBRANE POTENTIAL; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; SPHEROPLAST;

BOVINAE; ESCHERICHIA COLI;

EID: 77953872793     PISSN: 18671306     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12602-010-9039-2     Document Type: Article

References (45)

1. Al-Nabulsi AA, Holley RA (2006) Enhancing the antimicrobial effects of bovine lactoferrin against Escherichia coli O157: H7 by cation chelation, NaCl and temperature. J Appl Microbiol 100: 244-255.
2. Al-Nabulsi AA, Holley RA (2007) Effects on Escherichia coli O157: H7 and meat starter cultures of bovine lactoferrin in broth and microencapsulated lactoferrin in dry sausage batters. Intl J Food Microbiol 113: 84-91.
3. Bakker EP, Harold FM (1980) Energy coupling to potassium transport in Streptococcus faecalis. Interplay of ATP and the proton motive force. J Biol Chem 255: 433-440.
4. Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K, Tomita M (1992) Identification of the bactericidal domain of lactoferrin. Biochem Biophys Acta 1121: 130-136.
5. Bellamy WR, Wakabayashi H, Takase M, Kawase K, Shimamura S, Tomita M (1993) Role of cell-binding in the antibacterial mechanism of lactoferricin. J Appl Bacteriol 75: 478-484.
6. Birdsell DC, Cota-Robles EH (1967) Production and ultrastructure of lysozyme and ethylenediaminetetraacetate-lysozyme spheroplasts of Escherichia coli. J Bacteriol 93: 427-437.
7. Bonnett M, Rafi MM, Chikindas ML, Montville TJ (2006) Bioenergetic mechanism for nisin resistance, induced by the acid tolerance response of Listeria monocytogenes. Appl Environ Microbiol 72: 2556-2563.
8. Branen JK, Davidson PM (2003) Enhancement of nisin, lysozyme and monolaurin antimicrobial activities by ethylenediaminetetraacetic acid and lactoferrin. Intl J Food Microbiol 90: 63-74.
9. Chantaysakorn P, Richter RL (2000) Antimicrobial properties of pepsin-digested lactoferrin added to carrot juice and filtrates of carrot juice. J Food Prot 63: 376-380.
10. Chapple DS, Hussain R, Joannou CL, Hancock REW, Odell E, Evans RW, Siligardi G (2004) Structure and association of human lactoferrin peptides with Escherichia coli lipopolysaccharide. Antimicrob Agents Chemother 48: 2190-2198.
11. Crane JK, Nacher TM, Choudhari SS, Giroux EM (2005) Two pathways for ATP release from host cells in enteropathogenic Escherichia coli infection. Am J Physiol Gastrointest Liver Physiol 289: 407-417.
12. Dionysius DA, Grieve PA, Milne JM (1993) Forms of lactoferrin: their antibacterial effect on enterotoxigenic Escherichia coli. J Dairy Sci 76: 2597-2606.
13. Dionysius DA, Milne JM (1997) Antibacterial peptides of bovine lactoferrin: purification and characterization. J Dairy Sci 80: 667-674.
14. Drider D, Fimland G, Hechard Y, McMullen LM, Prevost H (2006) The continuing story of class IIa bacteriocins. Microbiol Mol Biol Rev 70: 564-582.
15. Ellison RT III, Giehl TJ (1991) Killing of Gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest 88: 1080-1091.
16. Ellison RT, Luo Q, Reller LB (1990) Enhancement of activity of cefotaxime by iron-binding proteins. J Antimicrob Chemother 25: 479-481.
17. Erdei J, Forsgren A, Naidu S (1994) Lactoferrin binds to porins OmpF and OmpC in Escherichia coli. Infect Immun 62: 1236-1240.
18. Farnaud S, Evans RW (2003) Lactoferrin-a multifunctional protein with antimicrobial properties. Molec Immunol 10: 395-405.
19. Farnaud S, Spiller C, Moriarty LC, Patel A, Gant V, Odell EW, Evans RW (2004) Interactions of Lactoferricin-derived proteins with LPS and antimicrobial activity. FEMS Microbiol Lett 233: 193-199.
20. Gumpert J, Cron H, Plapp R, Niersbach H, Hoischen C (1996) Synthesis and secretion of recombinant penicillin G acylase in bacterial L-forms. J Basic Microbiol 36: 89-98.
21. Haukland HH, Ulvante H, Sandvik K, Vorland LH (2001) The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm. FEBS Lett 508: 389-393.
22. Heller WT, Waring AJ, Lehrer RI, Harroun TA, Weiss TM, Yang L, Huang HW (2000) Membrane thinning effect of the beta-sheet antimicrobial protegrin. Biochemistry 39: 139-145.
23. Herranz C, Chen Y, Chung H-J, Cintas LM, Hernandez PE, Montville TJ, Chikindas ML (2001) Enterocin P selectively dissipates the membrane potential of Enterococcus faecium T136. Appl Environ Microbiol 67: 1689-1692.
24. Hoek KS, Milne JM, Grieve PA, Dionysius DA, Smith R (1996) Antibacterial activity of bovine lactoferrin-derived peptides. Antimicrob Agents Chemother 41: 54-59.
25. Hwang PM, Zhou N, Shan X, Arrowsmith CH, Vogel HJ (1998) Three-dimensial solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochem 37: 4288-4298.
26. Lee SY, Yim KS, Chang HN, Chang YK (1993) Construction of plasmid, estimation of plasmid stability, and use of stable plasmids for the production of poly (3-hydroxybutyric acid) by recombinant Escherichia coli. J Bacteriol 32: 203-211.
27. Montville TJ, Chen Y (1998) Mechanistic action of pediocin and nisin: recent progress and unresolved questions. Appl Microbiol Biotechnol 50: 511-519.
28. Murdock CA, Matthews KR (2002) Antibacterial activity of pepsin-digested lactoferrin on foodborne pathogens in buffered broth systems and ultra-high temperature milk with EDTA. J Appl Microbiol 93: 850-856.
29. Murdock CA, Cleveland J, Matthews KR, Chikindas ML (2007) The synergistic effect of nisin and lactoferrin on the inhibition of Listeria monocytogenes and Escherichia coli O157: H7. Lett Appl Microbiol 44: 255-261.
30. Naidu SS, Svensson U, Kishore AR, Naidu AS (1993) Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium. Antimicrob Agents Chemother 37: 240-245.
31. Naidu AS (ed) (2000) Lactoferrin in natural food antimicrobial systems. CRC Press, New York.
32. Ohmizo C, Yata M, Katsu T (2004) Bacterial cytoplasmic membrane permeability assay using ion-selective electrodes. J Microbiol Meth 59: 173-179.
33. Onoda T, Oshima A, Nakano S, Matsuno A (1987) Morphology, growth and reversion in stable L-form of Escherichia coli K12. J Gen Microbiol 133: 527-534.
34. Payne KD, Oliver SP, Davidson PM (1994) Comparison of EDTA and apo-lactoferrin with lysozyme on the growth of foodborne pathogenic and spoilage bacteria. J Food Prot 57: 62-65.
35. Pellegrini A (2003) Antimicrobial peptides from food proteins. Cur Pharm Design 9: 1225-1238.
36. Rangle JM, Sparling PH, Crowe C, Griffin PM, Swerdlow DL (2005) Epidemiology of Escherichia coli O157: H7 outbreaks, United States, 1982-2002. Emerg Infect Dis 11: 603-609.
37. Sallmann FR, Baveye-Descamps S, Pattus F, Salmon V, Branza N, Spik G, Legrand D (1999) Porins OmpC and PhoE of Escherichia coli as a specific cell-surface targets of human lactoferrin. J Biol Chem 274: 16107-16114.
38. Shimazaki K, Tazume T, Uji K, Tanaka M, Kumura H, Mikawa K, Shimo-Oka T (1998) Properties of a heparin-binding peptide derived from bovine lactoferrin. J Dairy Sci 81: 2841-2849.
39. Shin K, Yamauchi K, Teraguchi S, Hayasawa H, Tomita M, Otsuka Y, Yamazaki S (1998) Antibacterial activity of bovine lactoferrin and its peptides against enterohemorrhagic Escherichia coli O157: H7. Lett Appl Microbiol 26: 407-411.
40. Stock I, Burak S, Sherwood KJ, Gruger T, Wiedemann B (2003) Natural antimicrobial susceptibilities of strains of "unusual" Serratia species: S. ficaria, S. fonticola, S. odorifera, S. plymuthica and S. rubidaea. J Antimicrob Chemother 51: 865-885.
41. Su C, Brandt L (1995) Escherichia coli O157: H7 infection in humans. Ann Intern Med 123: 698-707.
42. Teunis P, Takumi K, Shinagawa K (2004) Dose response for infection by Escherichia coli O157: H7 from outbreak data. Risk Anal 24: 401-407.
43. Venkitanarayanan KS, Zhao T, Doyle MP (1999) Antibacterial effect of lactoferrin B on Escherichia coli O157: H7 in ground beef. J Food Prot 62: 747-750.
44. Vorland LH, Ulvante H, Andersen J, Haukland HH, Rekdal O, Svendsen JS, Gutteberg TJ (1999) Antibacterial effects of lactoferricin B. Scand J Infect Dis 31: 179-184.
45. Yamauchi K, Tomita M, Giehl TJ, Ellison RT III (1993) Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 61: 719-728.